DK1053012T3 - Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner - Google Patents

Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner

Info

Publication number
DK1053012T3
DK1053012T3 DK99906749T DK99906749T DK1053012T3 DK 1053012 T3 DK1053012 T3 DK 1053012T3 DK 99906749 T DK99906749 T DK 99906749T DK 99906749 T DK99906749 T DK 99906749T DK 1053012 T3 DK1053012 T3 DK 1053012T3
Authority
DK
Denmark
Prior art keywords
treatment
pharmaceutical compositions
hiv infections
inhibitor compounds
peg
Prior art date
Application number
DK99906749T
Other languages
Danish (da)
English (en)
Inventor
Vassilios I Avramis
Lewis Cohen
Original Assignee
Enzon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzon Pharmaceuticals Inc filed Critical Enzon Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1053012T3 publication Critical patent/DK1053012T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK99906749T 1998-02-09 1999-02-09 Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner DK1053012T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7406698P 1998-02-09 1998-02-09
PCT/US1999/002480 WO1999039732A1 (en) 1998-02-09 1999-02-09 Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections

Publications (1)

Publication Number Publication Date
DK1053012T3 true DK1053012T3 (da) 2003-11-17

Family

ID=22117505

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99906749T DK1053012T3 (da) 1998-02-09 1999-02-09 Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner

Country Status (10)

Country Link
EP (1) EP1053012B1 (de)
JP (1) JP2002502826A (de)
AT (1) ATE245444T1 (de)
AU (1) AU752434B2 (de)
CA (1) CA2319356A1 (de)
DE (1) DE69909747T2 (de)
DK (1) DK1053012T3 (de)
ES (1) ES2203072T3 (de)
WO (1) WO1999039732A1 (de)
ZA (1) ZA991029B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1181045A4 (de) * 1999-04-02 2003-04-23 Los Angeles Childrens Hospital Verwendung von asparaginase und glutaminase zur behandlung von autoimmunerkrankungen sowie erkrankungen der abstossung von knochenmark und empfänger
AU6894400A (en) * 1999-08-06 2001-03-05 Enzon Pharmaceuticals Inc. Composition and methods for treatment of HIV infection
EP1279406A4 (de) 2000-04-03 2007-10-24 Santen Pharmaceutical Co Ltd Transporters und arzneimittelabgabesysteme die diese verwenden
US6911460B2 (en) 2001-04-20 2005-06-28 Vion Pharmaceuticals, Inc. Antiviral agents and methods of treating viral infections
JP5271475B2 (ja) * 2002-11-26 2013-08-21 ザ ユニヴァーシティー オヴ シカゴ 微生物媒介上皮疾患の予防及び治療のための材料並びに方法
WO2006029507A1 (en) * 2004-09-13 2006-03-23 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Inhibition of feline calicivirus replication by asparaginase
CN101002945B (zh) 2006-01-20 2012-09-05 清华大学 一种用于肿瘤治疗的新型复合物
CN100475270C (zh) 2006-01-20 2009-04-08 清华大学 一种治疗肿瘤的药物及其应用
GB0608876D0 (en) * 2006-05-05 2006-06-14 Medivir Ab Combination therapy
CN101219219B (zh) 2007-01-10 2013-02-13 北京普罗吉生物科技发展有限公司 包含血管抑素或其片段的复合物、其制备方法及应用
WO2015033344A1 (en) * 2013-09-05 2015-03-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
MX2020005478A (es) * 2017-11-29 2020-08-27 Taiho Pharmaceutical Co Ltd Compuestos de sulfonamida y usos de los mismos.
US20210299233A1 (en) 2018-07-12 2021-09-30 The Children's Medical Center Corporation Method for treating cancer
CN115671102A (zh) * 2022-11-17 2023-02-03 中国科学院大学 3-ap在制备抑制痘病毒的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2600256B1 (fr) * 1986-06-19 1988-09-16 Inst Nat Sante Rech Med Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus
WO1998056410A1 (en) * 1997-06-09 1998-12-17 Childrens Hospital Los Angeles Utilization of wolinella succinogenes asparaginase to treat diseases associated with asparagine dependence

Also Published As

Publication number Publication date
DE69909747D1 (de) 2003-08-28
ES2203072T3 (es) 2004-04-01
JP2002502826A (ja) 2002-01-29
EP1053012A1 (de) 2000-11-22
EP1053012B1 (de) 2003-07-23
DE69909747T2 (de) 2004-04-15
ZA991029B (en) 1999-09-30
AU2658499A (en) 1999-08-23
WO1999039732A1 (en) 1999-08-12
AU752434B2 (en) 2002-09-19
ATE245444T1 (de) 2003-08-15
CA2319356A1 (en) 1999-08-12

Similar Documents

Publication Publication Date Title
ATE377011T1 (de) Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1- piperazinpentanamide als hiv-proteasehemmer
DK1053012T3 (da) Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner
EA200001030A1 (ru) Получение капсул и таблеток быстрорастворяющегося эфавиренза с использованием супердезинтеграторов
BR0013771A (pt) Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica
DE69531944D1 (de) Neue hiv-protease-inhibitoren
EA200200778A1 (ru) СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ИНФЕКЦИИ ГЕПАТИТА С В ОРГАНИЗМЕ ХОЗЯИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ПРОТИВ ФЛАВИВИРУСА, СОЕДИНЕНИЕ ФОРМУЛЫ Ib - АКТИВНЫЙ АГЕНТ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ИНФЕКЦИИ ГЕПАТИТА С ИЛИ ФЛАВИВИРУСА (ВАРИАНТЫ)
EA200701869A1 (ru) Пептидомиметические ингибиторы протеазы
GEP20104960B (en) USE OF [D-MeALa]3-[EtVal]4-CYCLOSPORIN FOR THE TREATMENT OF HEPATITIS C INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID [D-MeAla]3-[EtVal]4-CYCLOSPORIN
SG52628A1 (en) Substituted cyclic carbonyls and derivatives thereof useful as retrobiral protease inhibitors
ATE327246T1 (de) Hepatitis c tripeptid inhibitoren
EA200400585A1 (ru) N-замещённые гидроксипиримидинон-карбоксамидные ингибиторы вич интегразы
DE69814049D1 (de) Substituierte benzimidazole als nicht-nucleoside reverse transcriptase inhibitore
BR9607625A (pt) Inibidores de protease retroviral sulfonamida hidroxietilamino de aminoácido heterociclocarbonila
DE69430385D1 (de) Hiv-proteaseinhibitoren
WO2006044968A3 (en) Combination therapy for treating viral infections
HK1041444A1 (zh) 用於治療hiv感染的包含peg-天冬酰胺酶的藥物組合物
EE9700165A (et) Ühendite kombinatsioon, meetod ja farmatseutiline kompositsioon HIV proteaasi ja HIV pöördtranskriptaasi inhibeerimiseks ning HIV infektsiooni vältimiseks või raviks, või AIDS-i või ARC raviks
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
NO965591L (no) Kombinasjonsbehandling av HIV-infeksjon
EA200000513A1 (ru) Комбинированная терапия для лечения спид
NO20024522D0 (no) Sammensetninger med anti-hiv-aktivitet
DE69529678D1 (de) Kombinationen von hiv-protease inhibitoren
UA31078A (uk) Інгібітор вірусу імунодефіциту людини ( даримід )
TR199902508T2 (xx) HIV proteaz inhibit�rleri.
FI970565A0 (fi) HIV-proteaasia inhiboiva yhdistelmä